[1]
|
Madjid, M., Miller, C.C., Zarubaev, V.V., et al. (2007) Influenza Epidemics and Acute Respiratory Disease Activity Are Associated with a Surge in Autopsy-Confirmed Coronary Heart Disease Death: Results from 8 Years of Autopsies in 34,892 Subjects. European Heart Journal, 28, 1205-1210. https://doi.org/10.1093/eurheartj/ehm035
|
[2]
|
Smeeth, L., Thomas, S.L., Hall, A.J., et al. (2004) Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination. The New England Journal of Medicine, 351, 2611-2618. https://doi.org/10.1056/NEJMoa041747
|
[3]
|
Pshezhetsky, A.V. and Ashmarina, L.I. (2013) Desialylation of Surface Receptors as a New Dimension in Cell Signaling. Biochemis-try, 78, 736-745. https://doi.org/10.1134/S0006297913070067
|
[4]
|
Lipničanová, S., Chmelová, D., Ondrejovič, M., et al. (2020) Diversity of Sialidases Found in the Human Body—A Review. International Journal of Biological Macromolecules, 148, 857-868.
https://doi.org/10.1016/j.ijbiomac.2020.01.123
|
[5]
|
Glanz, V.Y., Myasoedova, V.A., Grechko, A.V., et al. (2019) Sialidase Activity in Human Pathologies. European Journal of Pharmacology, 842, 345-350. https://doi.org/10.1016/j.ejphar.2018.11.014
|
[6]
|
Heimerl, M., Sieve, I., Ricke-Hoch, M., et al. (2020) Neuramini-dase-1 Promotes Heart Failure after Ischemia/Reperfusion Injury by Affecting Cardiomyocytes and Invading Mono-cytes/Macrophages. Basic Research in Cardiology, 115, Article No. 62. https://doi.org/10.1007/s00395-020-00821-z
|
[7]
|
Cross, A.S., Hyun, S.W., Miranda-Ribera, A., et al. (2012) NEU1 and NEU3 Sialidase Activity Expressed in Human Lung Microvascular Endothelia: NEU1 Restrains Endothelial Cell Migration, Whereas NEU3 Does Not. Journal of Biological Chemistry, 287, 15966-15980. https://doi.org/10.1074/jbc.M112.346817
|
[8]
|
Lindberg, G. (2007) Resialylation of Sialic Acid Deficit Vascular Endothelium, Circulating Cells and Macromolecules May Counteract the Development of Atherosclerosis: A Hypothesis. Atherosclerosis, 192, 243-245.
https://doi.org/10.1016/j.atherosclerosis.2007.03.011
|
[9]
|
Zhang, L., Wei, T.T., Li, Y., et al. (2018) Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases. Circulation, 137, 1374-1390.
https://doi.org/10.1161/CIRCULATIONAHA.117.031139
|
[10]
|
Kumagai, R., Lu, X. and Kassab, G.S. (2009) Role of Glycocalyx in Flow-Induced Production of Nitric Oxide and Reactive Oxygen Species. Free Radical Biology and Medicine, 47, 600-607.
https://doi.org/10.1016/j.freeradbiomed.2009.05.034
|
[11]
|
Psefteli, P.M., Kitscha, P., Vizcay, G., et al. (2021) Gly-cocalyx Sialic Acids Regulate Nrf2-Mediated Signaling by Fluid Shear Stress in Human Endothelial Cells. Redox Biology, 38, Article ID: 101816.
https://doi.org/10.1016/j.redox.2020.101816
|
[12]
|
White, E.J., Gyulay, G., Lhoták, Š., et al. (2018) Sialidase Down-Regulation Reduces Non-HDL Cholesterol, Inhibits Leukocyte Transmigration, and Attenuates Atherosclerosis in ApoE Knockout Mice. Journal of Biological Chemistry, 293, 14689-14706. https://doi.org/10.1074/jbc.RA118.004589
|
[13]
|
Sieve, I., Ricke-Hoch, M., Kasten, M., et al. (2018) A Positive Feedback Loop between IL-1β, LPS and NEU1 May Promote Atherosclerosis by Enhancing a Pro-Inflammatory State in Monocytes and Macrophages. Vascular Pharmacology, 103-105, 16-28. https://doi.org/10.1016/j.vph.2018.01.005
|
[14]
|
Demina, E.P., Smutova, V., Pan, X., et al. (2021) Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages. Journal of the American Heart Association, 10, e018756. https://doi.org/10.1161/JAHA.120.018756
|
[15]
|
Cuniberti, L.A., Martinez, V., Schachter, J., et al. (2005) Sialic Acid as a Protective Barrier against Neointima Development. Atherosclerosis, 181, 225-231. https://doi.org/10.1016/j.atherosclerosis.2005.01.021
|
[16]
|
Gayral, S., Garnotel, R., Castaing-Berthou, A., et al. (2014) Elastin-Derived Peptides Potentiate Atherosclerosis through the Immune Neu1-PI3Kγ Pathway. Cardiovascular Research, 102, 118-127.
https://doi.org/10.1093/cvr/cvt336
|
[17]
|
Kawecki, C., Bocquet, O., Schmelzer, C.E.H., et al. (2019) Identification of CD36 as a New Interaction Partner of Membrane NEU1: Potential Implication in the Pro-Atherogenic Effects of the Elas-tin Receptor Complex. Cellular and Molecular Life Sciences, 76, 791-807. https://doi.org/10.1007/s00018-018-2978-6
|
[18]
|
Yang, A., Gyulay, G., Mitchell, M., et al. (2012) Hypomorphic Sialidase Expression Decreases Serum Cholesterol by Downregulation of VLDL Production in Mice. Journal of Lipid Research, 53, 2573-2585.
https://doi.org/10.1194/jlr.M027300
|
[19]
|
Piccoli, M., Coviello, S., Canali, M.E., et al. (2022) Neu3 Sialidase Acti-vates the RISK Cardioprotective Signaling Pathway During Ischemia and Reperfusion Injury (IRI). International Journal of Molecular Sciences, 23, Article 6090.
https://doi.org/10.3390/ijms23116090
|
[20]
|
Chen, Q.Q., Ma, G., Liu, J.F., et al. (2021) Neuraminidase 1 Is a Driver of Experimental Cardiac Hypertrophy. European Heart Journal, 42, 3770-3782. https://doi.org/10.1093/eurheartj/ehab347
|
[21]
|
Guo, Z., Fan, D., Liu, F.Y., et al. (2022) NEU1 Regulates Mito-chondrial Energy Metabolism and Oxidative Stress Post-Myocardial Infarction in Mice via the SIRT1/PGC-1 Alpha Axis. Frontiers in Cardiovascular Medicine, 9, Article 821317. https://doi.org/10.3389/fcvm.2022.821317
|
[22]
|
Ghiroldi, A., Piccoli, M., Creo, P., et al. (2020) Role of Sialidase Neu3 and Ganglioside GM3 in Cardiac Fibroblasts Activation. Biochemical Journal, 477, 3401-3415. https://doi.org/10.1042/BCJ20200360
|
[23]
|
Guo, Z., Tuo, H., Tang, N., et al. (2022) Neuraminidase 1 Deficiency Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, Inflammatory via AMPK-SIRT3 Pathway in Diabetic Cardiomyopathy Mice. International Journal of Biological Sciences, 18, 826-840. https://doi.org/10.7150/ijbs.65938
|
[24]
|
Qin, Y., Lv, C., Zhang, X., et al. (2021) Neuraminidase1 Inhibitor Protects against Doxorubicin-Induced Cardiotoxicity via Suppressing Drp1-Dependent Mitophagy. Frontiers in Cell and Devel-opmental Biology, 9, Article 802502.
https://doi.org/10.3389/fcell.2021.802502
|
[25]
|
Li, S., Wang, Y., Zeng, X., et al. (2022) Common Variants in Neu-raminidases Genes Contribute to Predisposition to and Progression of Chronic Heart Failure. Human Heredity, 87, 96-101. https://doi.org/10.1159/000525713
|
[26]
|
Dougherty, B.V., Rawls, K.D., Kolling, G.L., et al. (2021) Identi-fying Functional Metabolic Shifts in Heart Failure with the Integration of Omics Data and a Heart-Specific, Ge-nome-Scale Model. Cell Reports, 34, Article ID: 108836.
https://doi.org/10.1016/j.celrep.2021.108836
|
[27]
|
Li, C., Zhao, M., Xiao, L., et al. (2021) Prognostic Value of Ele-vated Levels of Plasma N-Acetylneuraminic Acid in Patients with Heart Failure. Circulation: Heart Failure, 14, e008459.
https://doi.org/10.1161/CIRCHEARTFAILURE.121.008459
|
[28]
|
Liu, J.N., Dolikun, M., Štambuk, J., et al. (2018) The Association between Subclass-Specific IgG Fc N-Glycosylation Profiles and Hypertension in the Uygur, Kazak, Kirgiz, and Tajik Populations. Journal of Human Hypertension, 32, 555-563. https://doi.org/10.1038/s41371-018-0071-0
|
[29]
|
Peng, J., Vongpatanasin, W., et al. (2019) Supplementation with the Sialic Acid Precursor N-Acetyl-D-Mannosamine Breaks the Link between Obesity and Hypertension. Circulation, 140, 2005-2018.
https://doi.org/10.1161/CIRCULATIONAHA.119.043490
|
[30]
|
Wang, Q., Chen, Z., et al. (2021) Neuraminidase 1 Exacerbating Aortic Dissection by Governing a Pro-Inflammatory Program in Macrophages. Frontiers in Cardiovascu-lar Medicine, 8, Article 788645.
https://doi.org/10.3389/fcvm.2021.788645
|
[31]
|
Poznyak, A.V., Zhang, D., Grechko, A.V., et al. (2020) The Role of Sialic Acids in the Initiation of Atherosclerosis. Minerva Cardioangiologica, 68, 359-364. https://doi.org/10.23736/S0026-4725.20.05145-2
|
[32]
|
Gökmen, S.S., Kazezoğlu, C., Sunar, B., et al. (2006) Rela-tionship between Serum Sialic Acids, Sialic Acid-Rich Inflammation-Sensitive Proteins and Cell Damage in Patients with Acute Myocardial Infarction. Clinical Chemistry and Laboratory Medicine, 44, 199-206. https://doi.org/10.1515/CCLM.2006.037
|
[33]
|
Rajendiran, K.S., Ananthanarayanan, R.H., Satheesh, S., et al. (2014) Elevated Levels of Serum Sialic Acid and High-Sensitivity C-Reactive Protein: Markers of Systemic Inflammation in Pa-tients with Chronic Heart Failure. British Journal of Biomedical Science, 71, 29-32. https://doi.org/10.1080/09674845.2014.11669959
|
[34]
|
Cheeseman, J., Kuhnle, G., Spencer, D.I.R., et al. (2021) Assays for the Identification and Quantification of Sialic Acids: Challenges, Opportunities and Future Perspectives. Bioorganic & Medicinal Chemistry, 30, Article ID: 115882.
https://doi.org/10.1016/j.bmc.2020.115882
|
[35]
|
Madjid, M., Curkendall, S. and Blumentals, W.A. (2009) The In-fluence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection. Cardiology, 113, 98-107. https://doi.org/10.1159/000172796
|
[36]
|
Casscells, S.W., Granger, E., Kress, A.M., et al. (2009) Use of Oseltami-vir after Influenza Infection Is Associated with Reduced Incidence of Recurrent Adverse Cardiovascular Outcomes among Military Health System Beneficiaries with Prior Cardiovascular Diseases. Circulation: Cardiovascular Quality and Outcomes, 2, 108-115.
https://doi.org/10.1161/CIRCOUTCOMES.108.820357
|
[37]
|
Wu, J., Zhao, M., Wei, H., et al. (2022) Neuramini-dase Inhibitor Treatment Is Associated with Decreased Mortality in COVID-19 Patients: A Retrospective Analysis. Eu-ropean Heart Journal—Cardiovascular Pharmacotherapy, 8, 392-401.
https://doi.org/10.1093/ehjcvp/pvac018
|
[38]
|
Lou, Y., Gan, J., Peppercorn, A., et al. (2013) Effect of Intravenous Zanamivir on Cardiac Repolarization. Pharmacotherapy, 33, 701-709. https://doi.org/10.1002/phar.1261
|